TEVA PHARMACEUTICAL INDUSTRIES LIMITED Accounts Payable, Trade, Current
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Accounts Payable, Trade, Current of $2.72 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes
us-gaap:AccountsPayableTradeCurrent · last filed 2026-07-29
- 2026-06-30: Accounts Payable, Trade, Current $2.72B.
- 2026-03-31: Accounts Payable, Trade, Current $2.60B.
- 2025-12-31: Accounts Payable, Trade, Current $2.53B.
- 2025-09-30: Accounts Payable, Trade, Current $2.35B.
| Period end | Accounts Payable, Trade, Current |
|---|---|
| 2026-06-30 | $2.72B 10-Q · filed 2026-07-29 |
| 2026-03-31 | $2.60B 10-Q · filed 2026-04-29 |
| 2025-12-31 | $2.53B 10-Q · filed 2026-07-29 |
| 2025-09-30 | $2.35B 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.50B 10-Q · filed 2025-07-30 |
| 2025-03-31 | $2.29B 10-Q · filed 2025-05-07 |
| 2024-12-31 | $2.20B 10-K · filed 2026-02-03 |
| 2024-09-30 | $2.37B 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.37B 10-Q · filed 2024-07-31 |
| 2024-03-31 | $2.44B 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.60B 10-K · filed 2025-02-05 |
| 2023-09-30 | $2.28B 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.51B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $2.38B 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.89B 10-K · filed 2024-02-12 |
| 2022-09-30 | $1.64B 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.90B 10-Q · filed 2022-07-27 |
| 2022-03-31 | $1.75B 10-Q · filed 2022-05-03 |
| 2021-12-31 | $1.69B 10-K · filed 2023-02-10 |
| 2021-09-30 | $1.51B 10-Q · filed 2021-10-27 |
| 2021-06-30 | $1.55B 10-Q · filed 2021-07-28 |
| 2021-03-31 | $1.69B 10-Q · filed 2021-04-28 |
| 2020-12-31 | $1.76B 10-K · filed 2022-02-09 |
| 2020-09-30 | $1.72B 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.61B 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.71B 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.72B 10-K · filed 2021-02-10 |